
52.17 BATS BZX Real-Time Price As of 1:41pm ET | ![]() Today’s Change | 37.08 Today|||52-Week Range 180.59 | -55.88% Year-to-Date |
The 22 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 125.00, with a high estimate of 207.00 and a low estimate of 54.00. The median estimate represents a +139.60% increase from the last price of 52.17.
The current consensus among 24 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.